KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Share-based Compensation (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Share-based Compensation readings, the most recent being $83.0 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 10.67% to $83.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $318.0 million, a 3.92% increase, with the full-year FY2025 number at $310.0 million, up 2.99% from a year prior.
  • Share-based Compensation hit $83.0 million in Q1 2026 for Thermo Fisher Scientific, down from $84.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $84.0 million in Q2 2024 to a low of $61.0 million in Q4 2023.
  • Median Share-based Compensation over the past 5 years was $76.0 million (2023), compared with a mean of $75.2 million.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 52.94% in 2022 and later dropped 18.67% in 2023.
  • Thermo Fisher Scientific's Share-based Compensation stood at $75.0 million in 2022, then dropped by 18.67% to $61.0 million in 2023, then rose by 29.51% to $79.0 million in 2024, then grew by 6.33% to $84.0 million in 2025, then decreased by 1.19% to $83.0 million in 2026.
  • The last three reported values for Share-based Compensation were $83.0 million (Q1 2026), $84.0 million (Q4 2025), and $70.0 million (Q3 2025) per Business Quant data.